We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPHR icon
526
Sphere Entertainment
SPHR
$5.01B
$631 ﹤0.01%
18
– –
MSGE icon
527
Madison Square Garden
MSGE
$3.66B
$616 ﹤0.01%
18
– –
HE icon
528
Hawaiian Electric Industries
HE
$2.28B
$595 ﹤0.01%
66
– –
RDDT icon
529
Reddit
RDDT
$34.5B
$575 ﹤0.01%
9
+4
+80% +$211
TWLO icon
530
Twilio
TWLO
$29.5B
$568 ﹤0.01%
+10
New +$590
DFTX
531
Definium Therapeutics
DFTX
$5.66B
$562 ﹤0.01%
78
+50
+179% +$437
CRSP icon
532
CRISPR Therapeutics
CRSP
$4.6B
$540 ﹤0.01%
10
-315
-97% -$18.2K
ZNTL icon
533
Zentalis Pharmaceuticals
ZNTL
$321M
$532 ﹤0.01%
130
– –
APPS icon
534
Digital Turbine
APPS
$1.04B
$515 ﹤0.01%
310
– –
ALDX icon
535
Aldeyra Therapeutics
ALDX
$95.6M
$513 ﹤0.01%
155
– –
JOBY icon
536
Joby Aviation
JOBY
$7.25B
$510 ﹤0.01%
100
– –
CLOU icon
537
Global X Cloud Computing ETF
CLOU
$227M
$501 ﹤0.01%
25
– –
DUK icon
538
Duke Energy
DUK
$100B
$501 ﹤0.01%
+5
New +$500
CUTR
539
DELISTED
Cutera, Inc.
CUTR
$477 ﹤0.01%
316
– –
PLUG icon
540
Plug Power
PLUG
$2.87B
$466 ﹤0.01%
200
– –
ACHR icon
541
Archer Aviation
ACHR
$3.78B
$458 ﹤0.01%
130
– –
MTTR
542
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$447 ﹤0.01%
+100
New +$379
OSUR icon
543
OraSure Technologies
OSUR
$273M
$426 ﹤0.01%
100
– –
BCX icon
544
BlackRock Resources & Commodities Strategy Trust
BCX
$894M
$413 ﹤0.01%
45
+1
+2% +$9
OUST icon
545
Ouster
OUST
$2.36B
$403 ﹤0.01%
41
– –
C icon
546
Citigroup
C
$223B
$375 ﹤0.01%
6
– –
TAC icon
547
TransAlta
TAC
$4.25B
$362 ﹤0.01%
51
– –
GRIN
548
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$359 ﹤0.01%
+26
New +$351
CHPT icon
549
ChargePoint
CHPT
$140M
$338 ﹤0.01%
11
– –
PEB icon
550
Pebblebrook Hotel Trust
PEB
$2.19B
$332 ﹤0.01%
24
– –
20 21
22
23 24

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.